Tag Archives: BIO CEO & Investor Conference

Announcing the BIO/Bloomberg Intelligence: 2015 Biotech Industry Outlook Survey

lab_tech

Click here for the BIO/Bloomberg Intelligence: 2015 Biotech Industry Outlook Survey. Your investment plans and budgets all include growth assumptions and market forecasts. Can you trust them? 2014 was another banner year for biotech IPOs, with 81 companies in our industry going public, an increase of nearly 90 percent over 2013. Now we turn our attention to the year ahead and what we can expect. More blue skies or dark clouds?  M&A surpassing last year Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,

Chairman Upton and Rep. DeGette Op-Ed: Can We Find Cures for 7,000 Diseases?

21st Century Cures Act

In a CNN.com op-ed, Energy & Commerce Committee Chairman Fred Upton (R-MI) and Representative Diana DeGette (D-CO) provide highlights of policies that they intend to propose to help get more cures and treatments for the more than 7,000 diseases for which only 500 have cures and treatments. Chairman Upton and Rep. DeGette launched the 21st Century Cures Initiative to identify areas of reform to help ‘close the gap between the science of medicine and the Read More >

Business and Investments, Events, Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Voting Now Open for the Buzz of BIO at the 2015 BIO CEO & Investor Conference

CEO-BuzzofBIO

The Buzz of BIO contest at the 2015 BIO CEO & Investor Conference recognizes highly innovative companies in the biotech sector and helps position these companies to develop strategic partnerships within the industry. Voting has officially opened for the below companies nominated in each of two categories – Most Distinguished Public Company and Most Promising Private Company. Winners will receive a complimentary company presentation and individual registration, plus promotion by BIO and BioCentury. The Most Distinguished Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

2015 BIO CEO & Investor Conference™ to Feature Dynamic List of Company Presentations

CEO-BuzzofBIO

Past and future attendees of the annual BIO CEO & Investor Conference have high expectations for the caliber of company’s chosen to present at the event. Presenting companies are hand selected for the event and consist of a selection of mid to large cap established public companies from around the globe who typically have a clinical stage program centered on therapeutics, molecular diagnostics, or a platform technology, as well as an upcoming clinical, regulatory or Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Looking Ahead to the 2014 BIO Investor Forum, Biotech IPO Hopefuls Continue to Seek Funding

partnering1

As mentioned in Fierce Biotech, a new crop of biotech IPO hopefuls have recently thrown their hats into the ring. These three biotechs are targeting $175M in IPO cash, hoping to secure funding for oncology, pain, and rare diseases. In fact, there have been 96 IPOs since the passage of the JOBS Act in April of 2012. One important provision of the Act is the ability for emerging growth companies to conduct “testing the waters” meetings with Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,